Literature DB >> 16647983

Prevalence of pH-documented laryngopharyngeal reflux in Chinese patients with clinically suspected reflux laryngitis.

Paul Lam1, William Ignace Wei, Yau Hui, Wai-kuen Ho.   

Abstract

PURPOSE: Laryngopharyngeal reflux (LPR) is one of the main factors behind different laryngeal pathology according to the Western literature. Literature reported that the prevalence of gastroesophageal reflux disease (GERD) in Chinese population was considerably lower than that in Western countries. To date, however, there is no study to evaluate the prevalence of pH-documented LPR in the Chinese ethnicity.
MATERIALS AND METHODS: We thus recruited 28 consecutive Chinese patients with reflux symptoms including globus, throat discomfort, throat clearing, chronic cough, or burping lasting more than 1 month in the preceding 1 year, together with stroboscopic evidence suggestive of reflux laryngitis according to the reflux finding score in our study. All patients underwent thorough head and neck examination and transnasal endoscopic assessment. The prevalence of pH-documented LPR and GERD was then documented using ambulatory 24-hour pH biprobe study.
RESULTS: Six (21%) of the 28 patients had pH-documented LPR. Four (14%) of the 28 patients had GERD with 3 of them having concomitant LPR. Only burping was associated with pH-documented LPR (P < .05). No relationship was observed between pH-documented LPR and other factors, including age, sex, other reflux symptoms except burping, and the reflux finding score.
CONCLUSION: Chinese patients do have and present with symptoms of extraesophageal reflux, and we observed a lower prevalence of pH-documented LPR in Chinese patients with clinically suspected reflux laryngitis compared with white patients.

Entities:  

Mesh:

Year:  2006        PMID: 16647983     DOI: 10.1016/j.amjoto.2005.09.012

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  2 in total

1.  Transcutaneous electrical acupoint stimulation for suspected laryngopharyngeal reflux disease.

Authors:  Hailong Shen; Yanxun Han; Changyu Yao; Ye Tao; Jing Wu; Chaobing Gao; Feihu Wu; Yehai Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-14       Impact factor: 3.236

2.  Trial of transcutaneous electrical acupoint stimulation in laryngopharyngeal reflux disease: study protocol for a randomized controlled trial.

Authors:  Hailong Shen; Yanxun Han; Di Wu; Lihong Hu; Yunxia Ma; Feihu Wu; Ye Tao; Yehai Liu
Journal:  Trials       Date:  2022-04-08       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.